Accueil / Communiqués / California Life Sciences Association (CLSA) Names Mike Guerra President & CEO of CLSA

California Life Sciences Association (CLSA) Names Mike Guerra President & CEO of CLSA

Tuesday, December 18th 2018 at 3:00pm UTC

Guerra to succeed Sara Radcliffe as organization transitions
leadership

SAN FRANCISCO & SACRAMENTO, Calif. & SAN DIEGO & WASHINGTON–(BUSINESS WIRE)– California
Life Sciences Association (CLSA)
, the trade association representing
California’s life sciences sector, today announced the appointment of
Mike Guerra as President and CEO of CLSA effective January 7, 2019. He
will succeed Sara Radcliffe, who will be departing the organization to
pursue new opportunities.

Mike Guerra is a seasoned business leader with extensive experience
within the California life sciences community. For much of the last 14
years Mike has held senior leadership positions with VWR International,
a leading global distributor and manufacturer of products to the life
sciences industry. His last role at VWR was Vice President of Sales for
the Western Region of the United States with responsibility for
companies in the pharmaceutical, biopharmaceutical, industrial and
production businesses. Mike most recently held the position of Vice
President of the Americas for Avidity Science, a worldwide leader in
water purification systems and laboratory equipment. While there, he
helped build and lead their life sciences business and channel strategy.

“Mike is an outstanding business leader who has worked for years with
many of the companies and organizations that are members of CLSA,” said
Bill Newell, California Life Sciences Association (CLSA) Board Chair.
“He has a passion for the mission of CLSA and a deep appreciation of the
tremendous advances being made by California’s life sciences ecosystem.
He is also very familiar with the challenges faced by innovative
organizations of all sizes. This will be extremely important to CLSA’s
continued success as the trade association representing the entire
California life sciences sector.

Newell added, “Sara Radcliffe was instrumental in building CLSA since it
was formed four years ago by the merger
of BayBio and the California Healthcare Institute (CHI)
. She built a
seasoned leadership team, including a stellar advocacy team in
Sacramento and Washington, DC who executed a strong advocacy agenda at
state and federal levels. She developed a strong brand and reputation
for CLSA which created substantial impact and influence across the state
for the benefit of patients, consumers, CLSA members and our entire
sector. The CLSA Board of Directors thanks her for her service and
dedication to CLSA’s mission and wishes her the very best as she pursues
new career opportunities.”

Radcliffe said, “I am extremely proud of all that CLSA has accomplished
in the four years that I have had the privilege of leading the
organization. Our federal, state and local legislative agenda has been
vigorously pursued. Our Business Solutions program has delivered real
economic value to our member companies. Finally, we have supported and
fostered our world-leading entrepreneurial community, which is as
vibrant in California as it has ever been. I am delighted to pass the
baton to Mike Guerra, with whom I have worked closely in his prior
roles. I have always been impressed by his leadership ability, his
dedication to excellence and his integrity. I know that with Mike at the
helm, CLSA will serve our members well and achieve its vital mission. I
thank the CLSA team for all they have accomplished and look forward to
working closely with Mike and the team through this transition.”

Mike Guerra said: “Sara has been at the forefront of every major issue
affecting California’s life sciences industry during her tenure as
President and CEO of CLSA. She has earned the respect of members,
policymakers, including elected officials, the venture community and
academic institutions alike. I am honored to have been selected to lead
the CLSA organization and look forward to growing the association as we
continue to cultivate strong relationships with officials locally, in
Sacramento and in Congress to ensure that California remains the global
leader in life sciences research, economic investment and job creation.
Our mission to advocate, connect and innovate for the benefit of our
entire California life sciences community will become even more
important in the coming years as we focus on bringing more value to
patients and communities throughout California.”

  • Learn
    More
     about the California life sciences sector
  • View
    CLSA’s Legislative Action Center
  • Watch
    CLSA’s Faces of California Biomedical Innovation Web Series
  • View
    CLSA’s Advocacy Priorities
  • View
    upcoming CLSA events
  • Meet
    the CLSA Board of Directors

About California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA) is the state’s largest and
most influential life sciences advocacy and business leadership
organization. With offices in Sacramento, San Diego, South San
Francisco, Los Angeles and Washington DC, CLSA works closely with
industry, government, academia and others to shape public policy,
improve access to innovative technologies and grow California’s life
sciences economy. CLSA serves biotechnology, pharmaceutical, medical
device and diagnostics companies, research universities and institutes,
investors and service providers throughout the Golden State. CLSA was
founded in 2015 when the Bay Area Bioscience Association (BayBio) and
the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org,
and follow us on Twitter @CALifeSciencesFacebookInstagramLinkedIn and YouTube.

Contacts

California Life Sciences Association (CLSA)
Will Zasadny |
Director, Communications
Wzasadny@califesciences.org
| 619-961-8848

Source: California Life Sciences Association


Voir aussi

Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRATM Platform at American Association for Cancer Research 2019 Annual Meeting

Saturday, March 30th 2019 at 12:00pm UTC – Pre-clinical Data Characterize the Conditional and Potent …